Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2025-12-28 @ 12:29 PM
Study NCT ID:
NCT06130566
Status:
COMPLETED
Last Update Posted:
2025-11-24
First Post:
2023-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-13
Completion Date Type:
ACTUAL
First Submit Date:
2023-11-08
First Submit QC Date:
None
Study First Post Date:
2023-11-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-19
Last Update Post Date:
2025-11-24
Last Update Post Date Type:
ESTIMATED